Screening \u00b7 Breast
Breast density in menopause: what it means for you
Dense breasts limit mammographic sensitivity and independently raise breast cancer risk. New FDA rules require notification. Supplemental ultrasound or MRI may be appropriate depending on lifetime risk.
Key points
- Know your BI-RADS density
- Ask about supplemental screening
- Track lifetime risk (Tyrer-Cuzick)
Frequently asked questions
What are dense breasts?
BI-RADS C or D on mammogram — more fibroglandular tissue, less fat.
Do I need extra screening?
Discuss ultrasound or MRI with your radiologist, especially if lifetime risk >20%.
Does HRT affect density?
Yes — combined HRT modestly increases density; transdermal + progesterone usually less so.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.